Latest Breaking News On - Shellyc lombard - Page 1 : comparemela.com

Form DEFA14A CATALYST BIOSCIENCES,

Form DEFA14A CATALYST BIOSCIENCES,
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesViia fviiaTrisha coltonShellyc lombardMatthew steckerExchange commissionExchange actCompany annual report on formSecurities exchangeCatalyst biosciences incStatement pursuantSecurities exchange actCommission onlyMaterial pursuantFiling proxy statementFiling fee

Catalyst Biosciences (CBIO) Announces Withdrawal of JDS1 Nominations to the Board

Catalyst Biosciences (CBIO) Announces Withdrawal of JDS1 Nominations to the Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shellyc lombardMatthew steckerCatalyst biosciences incIgor volshteynCatalyst boardWithdrawn candidates

INNOVATE Corp (VATE) Announces Directors Michael Gorzynski, Shelly Lombard and Kenneth Courtis Will Not Stand for Re-election

INNOVATE Corp (VATE) Announces Directors Michael Gorzynski, Shelly Lombard and Kenneth Courtis Will Not Stand for Re-election
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shellyc lombardKenneths courtisAvie glazerMichael gorzynskiEastern timeAnnual meeting

INNOVATE Corp Announces Directors Michael Gorzynski, Shelly Lombard and Kenneth Courtis Will Not Stand for Re-election

13.06.2022 - NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) - INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), today announced that directors Michael Gorzynski, Shelly C. Lombard and Kenneth S. Courtis have informed the Company that they will not stand for .

Shellyc lombardKenneths courtisMichael gorzynskiEastern time

Julian Singer Boosts Catalyst Biosciences Inc Stake, Upping Ante In Proxy Fight

Julian Singer, the son of famed activist investor Paul Singer of Elliott Management, said his JDS1 fund boosted its ownership stake in Catalyst Biosciences

Walter schlossShellyc lombardIgor volshteynMatthew steckerIzzy englanderExchange commissionVertex pharmaceuticals incCatalyst biosciences incJulian singerPaul singerElliott managementFull walter schloss seriesExodus pointMillennium managementVertex pharmaceuticalsAsset sale